8.02

6.08% 0.46

Pre-market: 8.09 0.07 +0.87%

Leonabio Inc (LONA)

Overview News Price History Discussions Forecast

Leonabio Inc stock is traded at $8.02, with a volume of 258.07K. It is up +6.08% in the last 24 hours and up +4.43% over the past month. LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Previous Close:

$7.56

Open:

$7.56

24h Volume:

258.07K

Relative Volume:

6.55

Market Cap:

$75.56M

Revenue:

Net Income/Loss:

$-129.41M

P/E Ratio:

-0.3329

EPS:

-24.0922

Net Cash Flow:

$-51.97M

1W Performance:

+5.67%

1M Performance:

+4.43%

6M Performance:

+51.32%

1Y Performance:

+0.00%

1-Day Range:

$7.43

$8.27

1-Week Range:

$7.43

$8.27

52-Week Range:

$4.21

$14.21

Leonabio Inc Stock (LONA) Company Profile

Name

Leonabio Inc

Sector

Healthcare (1085)

Industry

Biotechnology (606)

Phone

(425) 620-8501

Address

18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL

Employee

Twitter

Next Earnings Date

2026-08-20

Latest SEC Filings

LONA's Discussions on Twitter

Compare LONA vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LONA Leonabio Inc	8.02	71.23M	0	-129.41M	-51.97M	-24.09
VRTX Vertex Pharmaceuticals Inc	528.90	138.42B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	810.31	85.22B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,007.07	64.63B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	140.33	58.11B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	207.32	45.01B	742.00K	-1.37B	-1.07B	-7.0731

Leonabio Inc Stock (LONA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-26	Initiated	Cantor Fitzgerald	Overweight
Feb-19-26	Upgrade	Mizuho	Neutral → Outperform
Sep-19-24	Downgrade	Mizuho	Outperform → Neutral
Sep-04-24	Downgrade	BTIG Research	Buy → Neutral
Sep-04-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-04-24	Downgrade	Rodman & Renshaw	Buy → Neutral
Aug-19-24	Initiated	Rodman & Renshaw	Buy
Oct-17-22	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Jul-07-22	Initiated	Mizuho	Buy
Jun-23-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-23-22	Downgrade	Jefferies	Buy → Hold
Jun-23-22	Downgrade	Stifel	Buy → Hold
May-10-22	Initiated	BTIG Research	Buy
Apr-21-22	Initiated	Berenberg	Buy
Dec-15-21	Initiated	Goldman	Neutral
Oct-13-20	Initiated	Goldman	Buy
Oct-13-20	Initiated	JMP Securities	Mkt Outperform
Oct-13-20	Initiated	Jefferies	Buy
Oct-13-20	Initiated	Stifel	Buy

View All

Leonabio Inc Stock (LONA) Latest News

Sep 03, 2026

A drug developer's New York fireside chat is set for Sept. 11 - Stock Titan

Sep 03, 2026

Aug 31, 2026

Perceptive Advisors LLC Expands LeonaBio Inc (LONA) Stake in Str - GuruFocus

Aug 31, 2026

Sermonix Pharmaceuticals Discloses Investment at LeonaBio, Inc. with 36.9% Stake - TradingView

Aug 31, 2026

Prefunded warrants drive Sermonix-led LeonaBio (LONA) share shakeup - Stock Titan

Aug 31, 2026

Aug 28, 2026

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail

Aug 28, 2026

Aug 26, 2026

LeonaBio Reaches Key Phase 3 Enrollment Milestone - TipRanks

Aug 26, 2026

Aug 25, 2026

Perceptive's LeonaBio (NASDAQ: LONA) stake nears its ownership limit - Stock Titan

Aug 25, 2026

Aug 20, 2026

Anders Hove reports new passive stake in LeonaBio (LONA) - Stock Titan

Aug 20, 2026

Aug 19, 2026

LONA Maintained by Mizuho -- Price Target Lowered to $15.00 - GuruFocus

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Nigeria

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com

Aug 19, 2026

Analysts Are Bullish on These Healthcare Stocks: Cooper Co (COO), LeonaBio (LONA) - theglobeandmail.com

Aug 19, 2026

Aug 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 18, 2026

LeonaBio Reports Narrower Quarter Loss as Trial Progresses - sekbernews.id

Aug 18, 2026

LeonaBio: ELAINE-3 Enrollment Reaches 495 Of About 600 Patients As Up To $146 Million Of Warrant Proceeds Could Support Upcoming Milestones - Pulse 2.0

Aug 18, 2026

LeonaBio (LONA) Market Close: Closes 3.19% Higher at $7.96 at the Close; Level Check: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotLow Volatility Picks - vinanet.vn

Aug 18, 2026

Aug 17, 2026

LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks

Aug 17, 2026